Today: 20 March 2026
Subscribe
Browse Category

NYSE:UNH 21 October 2025 - 30 November 2025

UnitedHealth Group (UNH) Stock Outlook Before December 1, 2025: Can Bulls Look Past DOJ Risk and Medicare Pressures?

UnitedHealth Group (UNH) Stock Outlook Before December 1, 2025: Can Bulls Look Past DOJ Risk and Medicare Pressures?

UnitedHealth closed Friday at $329.77, down 47% from its 52-week high and about 34–35% lower year to date. The stock remains roughly 40% above its recent low, with after-hours trading at $329.50. Regulatory probes and lawsuits continue to weigh on sentiment despite a Q3 earnings beat and a 2.7% forward dividend yield. Institutional holders control about 88% of shares, with recent filings showing mixed activity.
30 November 2025
UnitedHealth Group (UNH) Stock Update – November 30, 2025: Fresh Valuation Warnings, New Buyers, and Persistent Regulatory Risk

UnitedHealth Group (UNH) Stock Update – November 30, 2025: Fresh Valuation Warnings, New Buyers, and Persistent Regulatory Risk

UnitedHealth closed at $329.77 on November 28, 2025, with a market cap near $299 billion. Shares remain down 34.6% year-to-date and 44.8% over the past year, despite a 3% gain this week. The stock has underperformed the S&P 500 since Q3 earnings. Institutional buying and new analyst coverage have increased recent trading activity.
30 November 2025
·
UnitedHealth Group (UNH) Stock on 29 November 2025: DOJ Probe, Medicare Advantage Shake‑Up and a 45% Slide

UnitedHealth Group (UNH) Stock on 29 November 2025: DOJ Probe, Medicare Advantage Shake‑Up and a 45% Slide

UnitedHealth Group shares closed at $329.77 on Nov. 28, down about 45% over the past year amid a DOJ investigation into Medicare Advantage billing. Third-quarter revenue rose 12% to $113.2 billion, but earnings from operations fell by half. The company raised its full-year earnings outlook and added former FDA commissioner Scott Gottlieb to its board. Institutional investors hold about 88% of the float.
29 November 2025
·
UnitedHealth Group (UNH) Stock Today, November 26, 2025: Price Action, Medicare Shockwaves and What Investors Are Watching

UnitedHealth Group (UNH) Stock Today, November 26, 2025: Price Action, Medicare Shockwaves and What Investors Are Watching

UnitedHealth Group shares rose 1.3% to about $330.63 on Wednesday, rebounding from Tuesday’s close of $326.28 amid news on Medicare commissions, hospital contract talks, and institutional trades. Despite the gain, the stock remains down 46% over the past year. UNH’s market cap stands near $289 billion, with a 52-week range of $234.60 to $622.83. New filings show mixed institutional interest as regulatory scrutiny intensifies.
26 November 2025
·
UnitedHealth Group (UNH) Stock Today, November 25, 2025: Price Surge, Reddit Buzz and New Red Flags for Investors

UnitedHealth Group (UNH) Stock Today, November 25, 2025: Price Surge, Reddit Buzz and New Red Flags for Investors

UnitedHealth shares rose about 2.7% to $327.70 in afternoon trading on November 25, helping lift the Dow as tech stocks weighed on the S&P 500. The stock remains down roughly 35% year-to-date and nearly 47% below its 52-week high. Trading volume topped 2.8 million shares mid-session. UNH has become a focus for retail investors on Reddit, despite its steep 2025 losses.
25 November 2025
·
UnitedHealth Group (UNH) Stock Today, November 24, 2025: ACA Subsidy Relief After a 50% Crash

UnitedHealth Group (UNH) Stock Today, November 24, 2025: ACA Subsidy Relief After a 50% Crash

UnitedHealth Group shares rose 0.6% to around $322 Monday, rebounding slightly after losing nearly half their value over the past year. The stock remains about 50% below its 52-week high, following earnings shocks and fallout from the Change Healthcare cyberattack. Reports that the White House may extend ACA premium subsidies lifted health insurers broadly. UNH’s market cap stands near $292 billion.
24 November 2025
·
Stock Market Today, Nov. 13, 2025: Dow Slides as Disney Plunges and Tech Stocks Drop After Trump Ends Record Shutdown

US Stock Market Today (Nov. 19, 2025): S&P 500 and Nasdaq Rebound as Wall Street Waits for Nvidia Earnings and Fed Minutes

Nvidia shares rose about 2% by midday Wednesday, leading a rebound in US tech stocks ahead of its earnings report after the bell. The S&P 500 climbed 0.25%, snapping a four-day losing streak, while the Nasdaq gained up to 0.8%. The Dow Jones slipped 0.2%, weighed down by UnitedHealth and Boeing. Investors awaited Nvidia’s results and Federal Reserve minutes later in the day.
19 November 2025
······
UnitedHealth Group Stock Surges Amid Analyst Upgrades: Is Wall Street Turning Bullish on UNH in 2025?

UNH Stock Forecast for 2026: Can UnitedHealth Survive the DOJ Storm and Medicare Cuts? (Updated November 15, 2025)

UnitedHealth Group shares traded near $321.86 on November 15, 2025, after a volatile year marked by a cyberattack, rising costs, and federal probes. The stock rebounded from a May low of $274, helped by Berkshire Hathaway’s stake. Q3 revenue rose 12% to $113.2 billion, but net margin was 2.1%. Management raised full-year guidance.
15 November 2025
··
Stock Market Today, Nov. 13, 2025: Dow Holds Near Record Above 48,000 as Longest U.S. Shutdown Ends

Stock Market Today, Nov. 13, 2025: Dow Holds Near Record Above 48,000 as Longest U.S. Shutdown Ends

The Dow Jones closed above 48,000 for the first time Wednesday, ending at 48,254.82. President Donald Trump signed a stopgap bill to end the 43-day U.S. government shutdown, funding operations until January 30. Stock futures edged lower early Thursday as traders weighed the reopening and shifting Fed expectations. Gold hovered near record highs, while Bitcoin traded around $103,000.
13 November 2025
·····
U.S. Stock Market Today (Nov. 12, 2025): Dow Closes Above 48,000 as House Preps Shutdown Vote; Nasdaq Slips

U.S. Stock Market Today (Nov. 12, 2025): Dow Closes Above 48,000 as House Preps Shutdown Vote; Nasdaq Slips

The Dow closed at a record 48,254.82, up 0.7%, as traders rotated out of tech stocks ahead of a key House vote to end the U.S. government shutdown. The S&P 500 edged up 0.1%, while the Nasdaq fell 0.3%. Oil prices dropped more than 4%, gold rose 1.7%, and Treasury yields eased to around 4.07%.
12 November 2025
·········
UnitedHealth Group Stock Surges Amid Analyst Upgrades: Is Wall Street Turning Bullish on UNH in 2025?

UnitedHealth (UNH) premarket: Dividend set, UBS talk at 8:45 a.m. ET, raised guidance — what to watch on November 10, 2025

UnitedHealth Group will appear at the UBS Global Healthcare Conference Monday after raising its 2025 guidance to at least $14.90 GAAP EPS and declaring a $2.21 quarterly dividend. The company closed its $3.3 billion Amedisys acquisition in August. About 78% of Medicare Advantage members are now in 4-star or higher plans. DOJ matters and 2026 medical cost trends remain under review.
9 November 2025
···
Dow Falls as Palantir Plunges – Is the AI Stock Boom Turning into a Bubble?

Dow Falls as Palantir Plunges – Is the AI Stock Boom Turning into a Bubble?

The Dow fell 0.5% Monday as UnitedHealth and Merck dropped, while the Nasdaq rose 0.5% on Amazon’s 4% jump after a $38 billion OpenAI deal. Palantir slid 8% despite beating revenue estimates, dragging other AI stocks lower. Wall Street leaders and Michael Burry warned of an AI-driven bubble and possible correction. Investors showed caution as weak manufacturing data and Fed policy jitters reversed early gains.
4 November 2025
·········
UnitedHealth Group Stock Surges Amid Analyst Upgrades: Is Wall Street Turning Bullish on UNH in 2025?

UnitedHealth (UNH) Premarket: Analysts Bullish on Comeback Despite 2025 Woes – What to Watch Nov. 3, 2025

UnitedHealth closed Nov. 1 at $341.56, down 0.93%, with a market cap near $309 billion. Q3 revenue rose 12% to $113.2 billion and adjusted EPS hit $2.92, both above forecasts; 2025 EPS guidance was raised. Shares remain down 30–35% YTD but have rebounded 10% from May lows. Wall Street’s median 12-month target is $390, with recent price hikes from Bernstein and KeyBanc.
2 November 2025
·
UnitedHealth Stock Rallies After Bold Strategy Overhaul – Is 2026 a Turning Point?

UnitedHealth Stock Rallies After Bold Strategy Overhaul – Is 2026 a Turning Point?

UnitedHealth reported Q3 revenue of $113.2 billion, up 12% year-over-year, and raised its 2025 adjusted EPS outlook to at least $16.25, above consensus. Shares traded near $360 on Oct. 29, about 30% below April’s peak. The company will shift more doctors to employment and exit lower-profit markets. Q3 medical-loss ratio was about 89.9%, and UnitedHealth remains under federal Medicare Advantage scrutiny.
29 October 2025
·
Stocks to Buy Today (Oct. 22, 2025): Top Picks as Markets Near Record Highs

Stocks to Buy Today (Oct. 22, 2025): Top Picks as Markets Near Record Highs

U.S. stock indexes hover near record highs after the Dow gained 0.5% Tuesday, while the Nasdaq slipped 0.2% on tech earnings misses. About 85% of S&P 500 companies have beaten forecasts, the highest rate in four years. AMD surged to record highs on AI chip deals, while Eli Lilly hit $935 on obesity drug demand. Netflix fell 6–7% pre-market after an earnings miss; Texas Instruments dropped nearly 9% on weak guidance.
22 October 2025
···········
Top 5 Stocks to Buy Now: October 22, 2025

Top 5 Stocks to Buy Now: October 22, 2025

AMD shares have surged 80% in 2025, hitting record highs near $240 on strong AI chip demand and new deals with OpenAI and Oracle; analysts now target $300. TSMC trades near $294 after a 45% rally, with Bank of America projecting $330 as AI chip demand soars. UnitedHealth rebounded to $364 after an early plunge, but remains 30% below January. BYD stock is down 30% from May highs despite strong overseas EV sales forecasts. Eli Lilly leads the U.S. obesity drug market, with Q1 sales of $6.1 billion
21 October 2025
····
1 … 6 7 8 9

Stock Market Today

  • FedEx Q3 Earnings Beat Estimates with $5.25 EPS on $24 Billion Revenue
    March 19, 2026, 7:00 PM EDT. FedEx reported third-quarter earnings of $5.25 per share, beating the Zacks Consensus Estimate of $4.14, marking a 26.81% earnings surprise. The package delivery giant's revenue rose to $24 billion, surpassing estimates by 1.75% and up from $22.16 billion a year ago. Shares have gained 21.1% year-to-date, outperforming the S&P 500's 3.2% decline. FedEx holds a Zacks Rank #3 (Hold) with mixed earnings estimate revisions ahead. The company's near-term stock performance will depend on management's commentary and future earnings trends in the Transportation - Air Freight and Cargo sector, currently ranked in the top 37% of Zacks industries.
Go toTop